Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News
FDA approves Gilead’s Livdelzi for treatment of primary biliary cholangitis
Gilead’s Livdelzi, a selective peroxisome proliferator-activated receptor delta agonist, has received accelerated FDA approval for the treatment of primary biliary cholangitis, according to a company release.
HCV elimination efforts in Georgia lower infections by 61%, may advance reaching 2030 goal
A hepatitis C elimination program in Georgia reduced the estimated annual incidence of new infections by 61% since its launch in April 2015, which may accelerate efforts to reach the global 2030 elimination goal.
Log in or Sign up for Free to view tailored content for your specialty!
IVIG reduces skin thickening, gastrointestinal symptoms in systemic sclerosis
Intravenous immunoglobulin treatment may benefit skin, musculoskeletal and gastrointestinal manifestations of systemic sclerosis, with low risks for adverse events, according to data published in Seminars in Arthritis and Rheumatism.
VIDEO: Interactive map spots priority zones to boost CRC screening in Hispanic, Latino adults
Researchers have identified priority areas in the U.S. where interventions are needed to improve colorectal cancer screening among Hispanic and Latino individuals with disproportionate access.
‘Aggressive’ treatment of GERD improves survival in systemic sclerosis with ILD
“Aggressive” combination therapy for gastroesophageal reflux disease improved survival among patients with systemic sclerosis and interstitial lung disease, according to data published in Arthritis Research & Therapy.
Mass screening for celiac disease in children ‘highly cost effective’ vs standard care
Earlier detection of celiac disease in children through mass screening or case-finding was “highly cost-effective” and improved long-term health outcomes vs. current practices, according to a study conducted in the Netherlands.
Tax-advantaged investing: Where to put your next dollar
As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.
Skyrizi outperforms Stelara in endoscopic remission at week 48 in Crohn’s disease
Although Skyrizi was noninferior to Stelara in clinical remission at week 24, it was superior in endoscopic remission at week 48 in patients with moderate to severe Crohn’s disease, according to data from the SEQUENCE trial.
Q&A: Diagnostic stewardship can reduce unneeded C. difficile testing
Diagnostic stewardship helped reduce the number of inappropriate tests ordered for Clostridioides difficile by 20 percentage points in a Florida health care system, according to a study.
Third person dies in multistate Listeria outbreak linked to deli meats
Another person has died in a multistate Listeria outbreak linked to sliced deli meats, bringing the death toll to three, according to the CDC.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read